Australians experience a higher percentage of pain than any country across the globe.

According to a major study conducted by Glaxo Smith Kline Group, seven in 10 Australians  experience body pain on a weekly basis.

Now an Australian born company has developed new drug-free technology which is providing pain relief for chronic pain and acute pain sufferers across the globe.

The new generation device PainPod Mi uses Micro Current Therapy which works at a level approximately 1000 times less than a Transcutaneous Electrical Stimulation Device (TENS) – and it cannot be felt by users.

The device mimics the body’s natural electrical microcurrent, helping cells to regenerate and repair, reducing inflammation and assisting in pain relief, rather than working as a pain blocker.

PainPod can harness the body’s bioelectrical system to moderate and manage pain levels, accelerate recovery and increase performance.

The device is small enough to fit in the palm of your hand – and easily fits into a pocket or handbag.

Nerve stimulation

The PainPod range includes the PainPod Mi and PainPod 3 Physical Therapy Device, with accessory hand and feet applications.

The PainPod 3 device works by delivering bio-electrical nerve stimulation pulses through the skin to the nerve endings in the affected area, blocking the pain signals from travelling to the brain. A 3-in-1 device, the PainPod 3 can block pain, accelerate recovery and increase performance levels through its 12 scientifically developed therapy modes.

PainPod’s bio-engineers have applied the latest scientific advances in biomedical, portable physical therapy devices to create a device that acts in harmony with the body’s biosystem.

Packaged as a non-invasive, wearable unit, the company has placed medically developed biotechnology directly into the hands of medical professionals, athletes and everyday users.

Broad range of applications

Targeting all levels of pain, the company says its product range is changing the lives of its varied users.

It can be used for a broad range of applications including chronic or acute pain in the body, nerve pain, rehabilitation, post-injury and surgery recovery, pre-natal, labour and post-natal pain and arthritis.

The device is being used with favourable results by many Australian athletes, including  Australian Volleyball Olympian Christie Mokotupu and former Australian Rugby League star Graham Eadie.

It can be used during exercise, to strengthen muscle fibres, providing faster training results, increased strength and optimal conditioning.Everyday users including children, pregnant women in their final trimester and the elderly can also use the new technology for pain management. 

“When formulating the design, it was important to develop beyond the current market and introduce the world to a targeted, easy-to-use pain relief device,” says Rick Rowan, CEO of PainPod. 

TGA approved

“PainPod has reviewed thousands of studies to develop our specific formulations. Our bioengineers and research teams are continually adapting to the latest technology so we can ensure everyone can experience a non-invasive, drug-free system of pain relief and recovery.” 

PainPod is being used and endorsed by leading doctors, physiotherapists, chiropractors and sport scientists throughout the world. 

It is approved on the register of Therapeutic Goods Australia and FDA listed.

PainPod is available from leading pharmacies, physiotherapists, chiropractors and online.

For more information: www.thepainpod.com